Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Why Baidu Stock Is Falling

Baidu Inc (NASDAQ: BIDU) shares are trading lower by 3.11% to $135.70 Tuesday afternoon. Shares of several Chinese companies at large are trading lower amid continued COVID-19 lockdowns in China. What Happened?
byHenry Khederian
September 6, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Baidu Inc (NASDAQ:BIDU) shares are trading lower by 3.11% to $135.70 Tuesday afternoon. Shares of several Chinese companies at large are trading lower amid continued COVID-19 lockdowns in China.

What Happened?

The Chinese city of Chengdu has asked the majority of its 21 million residents to stay home for three more days, as officials continued to fight flare-ups of COVID-19 elsewhere in the country, reported the Wall Street Journal.

China also said it would accelerate its stimulus rollout in the third quarter in an attempt to recover from the prior quarter marred by pandemic-related losses…Read More

See Also: Here’s Why HyreCar Shares Are Skyrocketing Over 50% Higher Tuesday

According to data from Benzinga Pro, Baidu has a 52-week high of $182.60 and a 52-week low of $101.62.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

What’s Going On With Crispr Therapeutics Stock?

By Erica Kollmann
February 15, 12:36 PM
Crispr Therapeutics shares are trading higher Thursday after Wolfe Research analyst Andy Chen initiated coverage on Crispr Therapeutics with a Peer Perform rating. Crispr Therapeutics' shares have risen nearly 37% over the past month following the FDA approval of Casgevy (exagamglogene autotemcel [exa-cel]), a CRISPR/Cas9 gene-edited cell therapy, for transfusion-dependent beta-thalassemia (TDT) in patients 12 years and older on Jan. 16.

CRSP